Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App-Based exercise shows promise for Post-COVID recovery

NCT ID NCT05770505

Symptom relief Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using an e-health tool to guide exercise can improve fitness and quality of life in adults who had COVID-19. Seventy-seven participants who struggled with physical activity after their infection were enrolled. The experimental group used the MIA Health app and a heart rate monitor to track exercise, while the control group received no follow-up. The study measured changes in cardiorespiratory fitness, lung function, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exercise training guided by an e-health tool
What this could lead to
If it works, this could offer a simple, home-based way to help people recover fitness and quality of life after COVID-19.
What could go wrong
This is a small, completed feasibility study with only 77 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

77 people

The number who actually took part.

Started

Apr 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Persons who have undergone COVID-19 disease * People who struggle to be physically active enough as a result of corona disease * People who experience reduced physical fitness as a result of corona disease Exclusion Criteria: \-- more than 100 AQ per week (calculated from self-reported activity level) * uncontrolled hypertension (high blood pressure) (over 200/110). * symptomatic valve failure, hypertrophic cardiomyopathy, unstable angina, pulmonary * hypertension, heart failure and/or severe rhythm disturbances * cancer that makes participation impossible or exercise contraindicated. Considered individually in consultation with the attending physician. * chronic contagious infectious diseases. * Participates in other studies that are not compatible with participation in this project * Post-exertional symptom exacerbation (PESE)/post-exertional malaise (PEM)/post-exertional neuroimmune exhaustion (PENE).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID -19

Contacts and locations

Locations

  • Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging,

    Trondheim, 7006, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.